We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
GSK plc | NYSE:GSK | NYSE | Depository Receipt |
Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.23 | 0.53% | 43.58 | 43.68 | 43.27 | 43.58 | 4,048,068 | 01:00:00 |
By Ian Walker
GlaxoSmithKline PLC has reported a market beating third-quarter net profit, and backed its full-year guidance. Here's what you need to know:
SALES: Sales for the quarter were 8.65 billion pounds ($11.28 billion) compared with GBP9.39 billion and a forecast of GBP8.82 billion, taken from FactSet and based on 11 analysts forecasts.
NET INCOME: Net profit was GBP1.24 billion, beating a consensus of GBP876.2 million, taken from FactSet and based on three analysts forecasts.
CORE EPS: Core EPS--a metric closely watched by analysts that strips out one-off items--came in at 35.60 pence and was up 1% on constant exchange rates. This compared with a forecast of 30.40 pence, taken from FactSet and based on 12 analysts estimates.
WHAT WE WATCHED:
-GUIDANCE: Glaxo reiterated that it expects adjusted EPS to decline by between 1% and 4% at constant rates in 2020, and would be at the lower end of this range on a CER basis. JPMorgan Cazenove had expected the company to direct expectations toward the more negative end of an anticipated drop.
-CORONAVIRUS: Chief Executive Emma Walmsley said the company is "urgently advancing" possible Covid-19 solutions with its partners, and expects see data on all of these before the end of the year.
-DIVIDENDS: Glaxo kept its fourth-quarter dividend unchanged at 19 pence a share but didn't say anything about the full-year payout. It had previously said the company plans to pay an unchanged dividend of 80 pence a share for the year.
Write to Ian Walker at ian.walker@wsj.com
(END) Dow Jones Newswires
October 28, 2020 09:17 ET (13:17 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year GSK Chart |
1 Month GSK Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions